BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31827398)

  • 1. SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways.
    Wang X; Zeng Y; Zhou M; Zhang X; Xu A; Lin J; Wu Z; Xie C; Luo J; Ding S; Zhan Z; Long H; Song Y
    Cancer Cell Int; 2019; 19():324. PubMed ID: 31827398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TROAP regulates cell cycle and promotes tumor progression through Wnt/β-Catenin signaling pathway in glioma cells.
    Zhao ZQ; Wu XJ; Cheng YH; Zhou YF; Ma XM; Zhang J; Heng XY; Feng F
    CNS Neurosci Ther; 2021 Jun; 27(9):1064-76. PubMed ID: 34077623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-protein Coupled Receptor 34 Promotes Gliomagenesis by Inducing Proliferation and Malignant Phenotype via TGF-Beta/Smad Signaling Pathway.
    Cheng Y; Heng X; Feng F
    Technol Cancer Res Treat; 2022; 21():15330338221105733. PubMed ID: 35770303
    [No Abstract]   [Full Text] [Related]  

  • 4. CUX1 Facilitates the Development of Oncogenic Properties
    Feng F; Zhao Z; Zhou Y; Cheng Y; Wu X; Heng X
    Front Mol Biosci; 2021; 8():705008. PubMed ID: 34422906
    [No Abstract]   [Full Text] [Related]  

  • 5. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway.
    Yao Y; Li X; Cheng L; Wu X; Wu B
    Bioengineered; 2021 Dec; 12(1):4032-4043. PubMed ID: 34288822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
    Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway.
    Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
    Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
    J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling.
    Liu H; Liu Z; Jiang B; Peng R; Ma Z; Lu J
    Cell Biochem Biophys; 2015 Sep; 73(1):205-12. PubMed ID: 25716338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells.
    Ma Q; Yang Y; Feng D; Zheng S; Meng R; Fa P; Zhao C; Liu H; Song R; Tao T; Yang L; Dai J; Wang S; Jiang WG; He J
    Oncotarget; 2015 Nov; 6(34):35851-65. PubMed ID: 26452219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRPK1 Promotes Glioma Proliferation, Migration, and Invasion through Activation of Wnt/β-Catenin and JAK-2/STAT-3 Signaling Pathways.
    Shi M; Sun D; Deng L; Liu J; Zhang MJ
    Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma.
    Song GQ; He TL; Ji KJ; Duan YM; Zhang JW; Hu GQ
    Front Oncol; 2022; 12():1038925. PubMed ID: 36439516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway.
    Xia S; Ji R; Zhan W
    BMC Neurol; 2017 Feb; 17(1):30. PubMed ID: 28187755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma.
    Chen C; Guo Q; Song Y; Xu G; Liu L
    Transl Lung Cancer Res; 2020 Apr; 9(2):218-231. PubMed ID: 32420061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
    Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
    Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC00339 promotes growth and invasiveness of hepatocellular carcinoma by the miR-1182/SKA1 pathway.
    Xiao J; Yu H; Ma Z
    Onco Targets Ther; 2019; 12():4481-4488. PubMed ID: 31239716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.